ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Trade (domestic/foreign) TRD

Issues related to implementation of US-Korea Free Trade Agreement Issues related to Non-tariff trade barriers in Turkey Issues related to US position on intellectual property matters in Canada

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS); SENATE

Consumer Issues/Safety/Products CSP

H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

Contacted: HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Bills named: H.R. 3026 (112th), H.R. 3839 (112th), H.R. 1483 (112th), H.R. 2245 (112th), H.R. 3668 (112th), S. 1882 (112th), S. 296 (112th)

Copyright/Patent/Trademark CPT

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics Issues related to US position on intellectual property matters in Canada

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2182 (112th), S. 1734 (112th)

Health Issues HCR

H.R. 2182, S. 1734 GAIN (Generating Antibiotic Incentives Now Act of 2011) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs S. Amend. t.2107 and related legislative proposals regarding prescription drug importation

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE

Bills named: H.R. 3668 (112th), H.R. 3026 (112th), S. 296 (112th), H.R. 1483 (112th), H.R. 3839 (112th), S. 1734 (112th), H.R. 2245 (112th), S. 1882 (112th), H.R. 2182 (112th)

Medicare/Medicaid MMM

HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements. HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (112th), H.R. 2190 (112th)

Pharmacy PHA

H.R. 5651, S. 3187 (Prescription Drug User Fee Act (PFUFA)) FDA funding issues, including issues such as user fees and future appropriations HR 4274 (PREA Authorization Act of 2012, Best Pharmaceuticals for Children Act and Pediatric Research Equity Act of 2003) and related legislation related to issues of pediatric exclusivity S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC)

Bills named: S. 3187 (112th), S. 2295 (112th), H.R. 5651 (112th), H.R. 4384 (112th), H.R. 4274 (112th)